Author: Alexander Lee

Alexander is the founder and author of Microcaps.ca, a leading resource for investors interested in the micro-cap stock market. With a passion for uncovering hidden gems in the world of small-cap stocks, Alexander combines in-depth research with years of experience in the financial markets to provide readers with valuable insights and timely analysis. Investors should conduct their own research or consult with a qualified investment advisor before making any investment decisions. The author of this article is not responsible for any gains or losses incurred from investing in companies mentioned.

BlinkLab Limited (ASX:BB1), an innovative digital healthcare company specializing in smartphone-based AI-powered neurometric tests for diagnosing neurodevelopmental conditions, is excited to announce a significant research and clinical collaboration with Mental Care Group (MCG) in The Netherlands. Key Points of the Partnership: – Established partnership with the fifth largest outpatient mental health care provider in Europe, Mental Care Group. – Partnership solidified after a successful pilot study conducted by Mental Care Group validated the effectiveness of BlinkLab’s technology in a clinical environment. – Initial study involving 184 participants revealed that children with ADHD exhibit heightened sensory sensitivity, quantifiable through sound-evoked eyelid…

Read More

In the second quarter, hedge funds made strategic adjustments to their portfolios, particularly in the technology sector, as they navigated the evolving landscape of the artificial intelligence market. While increasing their positions in notable companies such as Apple Inc., funds chose to trim holdings in Nvidia Corp., a move reflective of their response to the AI boom that had been propelling the US stock market. Apple Inc. experienced a significant surge in market value during this period, prompting hedge funds to collectively acquire over 8.5 million shares. Janus Henderson Group Plc and Third Point LLC were among the funds that…

Read More

The current stock market trend continues to show an upward trajectory despite macroeconomic uncertainties. Many Canadian stocks with strong fundamental businesses have the potential for further growth, driven by factors such as anticipated interest rate cuts, increased consumer discretionary spending, the integration of AI technology, and expectations of higher corporate earnings. Amidst this backdrop, here are five Canadian stocks that present promising investment opportunities for the next five years. One notable stock is Constellation Software, a specialized software and services provider that has shown a 27% year-to-date increase in its stock price. With a focus on acquiring profitable companies with…

Read More

The launch of OpenAI’s ChatGPT in late 2022 has generated significant excitement within the generative artificial intelligence (AI) industry. While hardware companies have profited from selling chips needed to run and train these complex algorithms, the consumer-facing software side of the industry has seen fewer successes. SoundHound AI is positioned to change this landscape with its industry-leading AI voice and speech recognition software, which is already being used in real-world applications. Founded in 2005 and going public through a special purpose acquisition company merger in 2022, SoundHound AI has developed audio technology products, including in-car music and speech recognition software.…

Read More

Optimi Health (CSE: OPTI) recently announced the successful completion of the first export of its GMP-validated MDMA capsules to Australia. This export is intended for the treatment of post-traumatic stress disorder (PTSD) under Australia’s Authorised Prescriber Scheme. The company stated that the first group of patients will commence MDMA-assisted therapy capsules in the upcoming weeks, utilizing its GMP-validated 40mg and 60mg MDMA capsules. This development signifies a significant milestone for Optimi Health in its efforts to gather real-world evidence and patient-reported outcomes for MDMA-assisted therapy in PTSD patients in Australia. Additionally, the company has obtained an export permit from Health…

Read More

Therma Bright Inc.’s Digital Cough Technology (DCT) is being considered for a new chronic cough drug in a U.S.-based clinical trial. The AI-powered platform, developed in collaboration with smart-health company AI4LYF, aims to enhance healthcare decision-making by improving the collection, organization, and presentation of cough and respiratory data. Therma Bright holds exclusive worldwide licensing rights to market and sell products based on AI4LYF’s DCT. This mobile app enables the recording and collection of cough sounds using a smartphone, with AI-machine learning technology that can detect various respiratory diseases through changes in cough features. Studies have indicated a correlation between cough…

Read More

According to a recent report by Reuters, long-term uranium contract prices have reached a 16-year high due to uncertainties in the supply chain and increased demand from utilities looking to secure fuel for expanding capacity to power AI data centers. Currently, term prices are hovering around US$79 per pound, the highest since 2008, with further price hikes anticipated in the near future. As of the latest update, the uranium spot price stands at US$82.35, as reported by Business Insider, showing a slight decrease from last week’s price of $83.15. In other news, Skyharbour Resources (TSXV: SYH) announced a recent agreement…

Read More

The Canadian stock market experienced a mixed week, starting positively but ultimately facing declines across various sectors after last week’s poor performance. The recent reduction in the Bank of Canada’s overnight rate to 4.5 percent did not instill confidence in the market, as the central bank continues its balance sheet normalization policy, contributing to uncertainty among investors. In the mining sector, Victoria Gold Corp. faced challenges following a catastrophic cyanide solution spill at its Eagle mine in the Yukon Territory. While initial environmental samples showed concerning cyanide levels, recent tests indicate no detectable levels beyond drinking water guidelines. However, experts…

Read More

In recent weeks, there has been significant positive momentum for a cannabis company, with shares continuing to rise due to favorable news in the United States. The surge in share price, up to 80%, was driven by reports of potential reclassification of marijuana by the Drug Enforcement Administration (DEA). This development, if realized, could have a significant impact on the industry as marijuana is currently classified as a Schedule I substance federally. While the news has generated excitement and optimism for the future of the company, it is important to note that there are still uncertainties and hurdles to overcome.…

Read More

The Toronto Stock Exchange (TSX) has experienced notable volatility in 2024, with certain stocks showing underperformance despite broader market gains. Among the laggards are First Quantum Minerals, Magna International, and Canadian Tire Corporation. While some may interpret this as a cautionary signal, others may see it as an opportunity for potential investment. First Quantum Minerals has encountered challenges this year, reporting a net loss in the first quarter of 2024 due to issues at its Cobre Panamá mine and other operational hurdles. Despite this, the company remains focused on its expansion projects and improving conditions at its mines. Analysts anticipate…

Read More